2024 annual financial data
Seres Therapeutics 2024 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -121.32M USD and net income was -146.57M USD.
Operating cash flow was -148.61M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -121.32M USD
- Net income
- -146.57M USD
- Operating cash flow
- -148.61M USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Seres Therapeutics financial years